Effect of endothelin-1 in man: impact on basal and adrenocorticotropin-stimulated concentrations of aldosterone.
H. Vierhapper, P. Nowotny, W Waldhäusl
Abstract
H. Vierhapper, P. Nowotny, W Waldhäusl
Abstract
The effect of exogenous endothelin-1 [2 pmol (5 ng)/kg.min for 15 min, followed by 1 pmol (2.5 ng)/kg.min for 105 min] on basal and ACTH (250 micrograms, i.v.)-stimulated plasma concentrations of aldosterone, cortisol, testosterone, corticosterone, and 18-hydroxycorticosterone was investigated in a group of healthy male volunteers (n = 6). Plasma concentrations of aldosterone remained unchanged during a placebo experiment (i.e. in the absence of both exogenous ACTH and of endothelin-1). In the absence of exogenous ACTH, the i.v. administration of endothelin-1 did not influence plasma concentrations of aldosterone. The i.v. administration of 0.25 mg ACTH induced a rise in plasma concentrations of aldosterone from a basal value of 152.6 +/- 38.8 to 362.6 +/- 77.7 pmol/L. This ACTH-induced rise was markedly augmented (P < 0.01) by the concomitant administration of endothelin-1, when peak plasma concentrations of aldosterone of 632.5 +/- 230.2 pmol/L were observed. Basal and ACTH-stimulated concentrations of cortisol, corticosterone, and 18-hydroxycorticosterone were unchanged by the concomitant infusion of endothelin-1. Thus, exogenous endothelin-1 influences adrenal function in healthy men by selectively augmenting the ACTH-induced secretion of aldosterone.
OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The effect of exogenous endothelin-1 [2 pmol (5 ng)/kg.min for 15 min, followed by 1 pmol (2.5 ng)/kg.min for 105 min] on basal and ACTH (250 micrograms, i.v.)-stimulated plasma concentrations of aldosterone, cortisol, testosterone, corticosterone, and 18-hydroxycorticosterone was investigated in a group of healthy male volunteers (n = 6). Plasma concentrations of aldosterone remained unchanged during a placebo experiment (i.e. in the absence of both exogenous ACTH and of endothelin-1). In the absence of exogenous ACTH, the i.v. administration of endothelin-1 did not influence plasma concentrations of aldosterone. The i.v. administration of 0.25 mg ACTH induced a rise in plasma concentrations of aldosterone from a basal value of 152.6 +/- 38.8 to 362.6 +/- 77.7 pmol/L. This ACTH-induced rise was markedly augmented (P < 0.01) by the concomitant administration of endothelin-1, when peak plasma concentrations of aldosterone of 632.5 +/- 230.2 pmol/L were observed. Basal and ACTH-stimulated concentrations of cortisol, corticosterone, and 18-hydroxycorticosterone were unchanged by the concomitant infusion of endothelin-1. Thus, exogenous endothelin-1 influences adrenal function in healthy men by selectively augmenting the ACTH-induced secretion of aldosterone.
Key concepts: Aldosterone, Internal medicine, Endocrinology, Corticosterone, Basal (medicine), Endothelin 1, Endothelin receptor, Chemistry